Biotech Articles and Guides
TickerPosts guides and articles tagged biotech. Plain-English, calm, and written for everyday investors. 4 posts.
ImmunityBio (IBRX) Stock News: FDA Expands Anktiva Approval to All BCG-Unresponsive Bladder Cancer
The FDA expanded Anktiva’s approval to cover BCG-unresponsive non-muscle-invasive bladder cancer with papillary-only tumors, the first approval to include that group, which the company says is about 85% of patients.
· 1 min read
Prelude Therapeutics (PRLD) and Lilly (LLY) Stock News: Trial Collaboration Pairs an Experimental Degrader With Two Lilly Drugs
Prelude signed a clinical trial collaboration and supply agreement with Eli Lilly to test its KAT6A degrader PRT13722 alongside Verzenio and Inluriyo in HR-positive, HER2-negative breast cancer.
· 1 min read
Biogen (BIIB) Stock News: JPMorgan Upgrades to Overweight on 2027 Trial Readouts
JPMorgan upgraded Biogen to Overweight with a $300 target, up from $210, pointing to three clinical readouts by 2027 led by felzartamab in transplant rejection.
· 1 min read
Eli Lilly Strikes a $2.8 Billion AtaiBeckley Biotech Deal
Lilly's planned acquisition of AtaiBeckley pushes big pharma deeper into neuroscience and psychedelic-derived mental-health therapies.
· 1 min read